pubmed-article:14998840 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14998840 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
pubmed-article:14998840 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:14998840 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
pubmed-article:14998840 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
pubmed-article:14998840 | lifeskim:mentions | umls-concept:C0205420 | lld:lifeskim |
pubmed-article:14998840 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:14998840 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
pubmed-article:14998840 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:14998840 | pubmed:dateCreated | 2004-3-4 | lld:pubmed |
pubmed-article:14998840 | pubmed:abstractText | To report the efficacy of induction treatment (IT) protocol with concurrent radiochemotherapy in locally advanced non-small-cell lung cancer (NSCLC), and to analyze downstaging as a surrogate end point. | lld:pubmed |
pubmed-article:14998840 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14998840 | pubmed:language | eng | lld:pubmed |
pubmed-article:14998840 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14998840 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14998840 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14998840 | pubmed:month | Mar | lld:pubmed |
pubmed-article:14998840 | pubmed:issn | 0923-7534 | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:ToniniGG | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:CelliniNN | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:TrodellaLL | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:ValentiniVV | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:CesarioAA | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:MacisGG | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:ValenteSS | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:CorboG MGM | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:GranonePP | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:MargaritoraSS | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:RamellaSS | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:CiresaMM | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:GalettaDD | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:PorziellaVV | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:VincenziBB | lld:pubmed |
pubmed-article:14998840 | pubmed:author | pubmed-author:D'AngelilloR... | lld:pubmed |
pubmed-article:14998840 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14998840 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:14998840 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14998840 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14998840 | pubmed:pagination | 389-98 | lld:pubmed |
pubmed-article:14998840 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:meshHeading | pubmed-meshheading:14998840... | lld:pubmed |
pubmed-article:14998840 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:14998840 | pubmed:articleTitle | Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging. | lld:pubmed |
pubmed-article:14998840 | pubmed:affiliation | Department of Radiation Oncology, Università Cattolica del S Cuore, Rome, Italy. ltrodella@rm.unicatt.it | lld:pubmed |
pubmed-article:14998840 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14998840 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:14998840 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:14998840 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14998840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14998840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14998840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14998840 | lld:pubmed |